Influenza vaccine safe for children

Use of the influenza vaccine in children 6 to 23 months is not associated with an increased risk for a medical visit for any serious conditions, claims a study published in JAMA.

  • E-Mail
By  Joanne Bladd Published  November 8, 2006

Use of the influenza vaccine in children 6 to 23 months is not associated with an increased risk for a medical visit for any serious conditions, claims a study published in JAMA. Until recently, the trivalent inactivated influenza vaccine was recommended only for adults and children with known chronic medical conditions that could put them at higher risk from influenza infection, such as asthma. But in 2004, the US-based Centers for Disease Control and Prevention recommended use of this vaccine in all children 6 to 23 months old, including healthy children with no chronic medical condition, following increasing evidence of high rates of illness from influenza infection in young children. However, the vaccine’s safety in young children has not been adequately studied in large populations. Dr Simon J. Hambidge, of Kaiser Permanente Colorado, Denver, and colleagues evaluated the safety of trivalent inactivated influenza vaccine in a large population of children 6 to 23 months old. Participants received trivalent inactivated influenza vaccine between 1 January, 1991, and 31 May 2003 (45,356 children with 69,359 vaccinations). The researchers analysed data on significant medically attended events that occurred after vaccination during “risk windows”, and compared them with events that occurred in two control periods, one before vaccination and the second after the risk window. These medically attended events, such as acute respiratory tract infection, asthma, cough and pneumonia, were reviewed at eight managed care organisations. The researchers found that no conditions were significantly more likely to occur within either the 3-day, the 1- to 42-day, or the 15- to 42-day risk windows compared with both control windows. During the 1-14 day risk window, there was a very slight increase in visits for mild vomiting and diarrhoea to outpatient doctor’s clinics, but less visits for asthma, cough, and the common cold. “While our findings offer reassurance regarding the safety of the vaccine in the youngest children, large safety studies of influenza vaccine in children in the newly recommended age group of children 3 to 5 years old are needed,” the authors conclude. “Our study, the largest safety study of trivalent inactivated influenza vaccine in children aged 6 to 23 months, adds to prior evidence that influenza vaccine is safe in infants and young children.”

Add a Comment

Your display name This field is mandatory

Your e-mail address This field is mandatory (Your e-mail address won't be published)

Security code